[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Wegovy

Novo Nordisk's Wegovy receives a positive opinion from the EMA for a higher XXX mg dose, potentially offering greater weight loss, while news also highlights concerns about stomach paralysis from GLP-1 drugs.

About Wegovy

Wegovy is a prescription medication used for weight loss.

Insights

Engagements: XXXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXX +531%
X Month: XXXXXXXXX -XX%
X Months: XXXXXXXXXXX -XX%
X Year: XXXXXXXXXXX -XX%
1-Year High: XXXXXXXXX on 2025-03-10
1-Year Low: XX on 2025-11-04

Engagements by network (24h): News: XXXXX Reddit: XXXXX TikTok: XXXXXXX X: XXXXXX YouTube: XXXXXXX

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX +194%
X Month: XXXXX -XX%
X Months: XXXXXX -XX%
X Year: XXXXXX -XXXX%
1-Year High: XXXXX on 2025-06-24
1-Year Low: X on 2025-12-02

Mentions by network (24h): News: XXX Reddit: XXX TikTok: XXXXX X: XXX YouTube: XXXXX

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Wegovy in the last XX hours which is up XXXX% from XXX in the previous XX hours Daily Average: XXX
X Week: XXXXX +161%
X Month: XXXXX -XX%
X Months: XXXXXX -XX%
X Year: XXXXXX -XX%
1-Year High: XXXXX on 2025-06-24
1-Year Low: X on 2025-12-02

The most influential creators that mention Wegovy in the last XX hours

Creator Rank Followers Posts Engagements
@bazghakhalidmd X XXXXXX X XXXXX
@sierra.robichaud X XXXXXX XX XXXXX
@my.journey.with.marc X X XXXXX
@regenicswomenshealth X XXXXX X XXXXX
@drkjoseph1 X XXXXXX X XXXXX
@taylormaemcd X XXXXXXX X XXXXX
@glp X XXXXX X XXXXX
@newscientist X XXXXXXXXXXX X XXXXX
@hopiedopiee1 X XXXXXXX X XXXXX
@drmcgowanmd XX XXXXXX X XXXXX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% +7%
X Year: XX% +7%
1-Year High: XXX% on 2025-10-31
1-Year Low: XX% on 2025-11-13

Most Supportive Themes:

Most Critical Themes:

Top Wegovy News

Top news links shared on social in the last XX hours

Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.

"The potential of GLP-1 drugs to transform medicine exploded in 2025 New Scientist"
News Link @newscientist 2025-12-11T20:22Z 208.1M followers, 27.1K engagements

"Semaglutide fails to slow progression of Alzheimers in highly anticipated trials Novo Nordisk says CNN"
News Link @CNN 2025-11-24T16:16Z 60.9M followers, 2431 engagements

"Hotdogs and motorways: The ripples created by Denmark's Ozempic and Wegovy boom - BBC Worklife"
News Link @Telegraph 2025-06-05T09:01Z 228.6M followers, 520.6K engagements

"This weight loss drug helped people shed more pounds than Wegovy new trial results show"
News Link @NaturePortfolio 2024-12-04T11:45Z 9.3M followers, 100.6K engagements

Top Wegovy Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"On GLP-1 Stop Scrolling and Read the captions #mounjaro #zepbound #wegovy"
YouTube Link @coachinsiya 2025-12-15T02:18Z XXX followers, 2113 engagements

"$NOV $NVO is the best investment of 2026 After a massive 2025 reset Novo is primed for a monster 2026: Pipeline: Next-gen CagriSema & Amycretin results Market: Oral Wegovy launch to 10x accessibility Efficiency: $1B+ in cost savings via restructuring. Price Target: $100"
X Link @RockBolig 2025-12-14T14:28Z XXX followers, 1300 engagements

"$NVO is trading as if the obesity drug boom never happened. The stock is down over XX% this year after trial disappointments profit warnings and rising competition. Several years of gains post Wegovy approval have been wiped out and sentiment has clearly shifted. Investors now question pipeline depth and post semaglutide growth with the key US patent expiring in 2032. Bulls point to potential catalysts ahead: a higher dose Wegovy shot an oral obesity pill and better execution under new leadership. At 14x earnings Novo trades at roughly half its X year average valuation. The debate is no"
X Link @investseekers 2025-12-14T07:25Z 4927 followers, 12.1K engagements

"Treatment penurun berat badan efektif ala artis #beratbadanideal #ozempic #wegovy"
YouTube Link @threeleanoraestheticclinic 2025-12-14T07:12Z XXX followers, XXX engagements